SME IPOs list on NSE Emerge or BSE SME. They are real public offers with a prospectus, a registrar, and a listing. They are also where retail readers import mainboard habits and get hurt by liquidity, ticket size, and a disclosure standard they did not actually read. The risks below are structural. They apply even when the GMP is exciting. Especially when the GMP is exciting.
The cheque is larger
The minimum application on an SME issue is a bigger block of rupees than a typical mainboard lot. The regulator has raised that floor over time, and the binding number is in the prospectus in front of you, so do the multiplication from that document. A large minimum changes behaviour. You cannot “try one small lot” the way you might on the main board. You are putting a meaningful slice of savings into a single small company, often a business you had not heard of a month earlier. Position size is the risk. A 20% listing gain on a cheque that was too big for you is not a success if a 20% listing loss would have been a problem. The premium does not know your other holdings.
The market after listing can be a rumour of a market
Mainboard issues, particularly heavily subscribed ones, tend to trade. SME issues often do not. Spreads are wide. A few lots set the last price. Circuit limits can trap you on the wrong side for more than one day. The price you see in a grey-market message is a quote in an unofficial market that was already thin. The price you see after listing is an official print that may still be thin. Neither is a promise that your full allotment can exit at that number.
If your plan is “sell on listing”, write down what you will do if the bid quantity at the open is smaller than your allotment. If you do not have an answer, the plan is incomplete. Listing day describes the auction. On SME platforms the quantity column matters more than the percentage column.
Information is thinner, and the company is younger in spirit
SEBI has tightened which companies may come to the SME platform: operating track record, profitability, and caps on how much existing shareholders can sell have all been part of that tightening. Those filters remove some weak files. They do not turn the survivors into large, researched companies. Analyst coverage after listing may be absent. The prospectus may be the only serious document anyone writes about the business all year. That makes the prospectus more important, not less. How to read a DRHP is the route. Customer concentration, related-party dealings, and promoter pledges are not footnotes in a 40-person firm. They are the firm.
Promoter control is usually heavier than in a widely held mainboard company. You are a minority shareholder in a business that may still be run like a private company. Related-party transactions, royalty arrangements, and guarantees need a plain reading. If you cannot explain them in two sentences, you are not an informed applicant yet.
Subscription and GMP mislead in specific ways
An SME book can be subscribed dozens of times by individual applicants writing large cheques, without a diversified institutional anchor book of the kind a mainboard issue advertises. The multiple is real. The interpretation “institutions love this” may be false. Read the category split. If the tracker’s QIB column is empty or tiny, do not imagine a hidden QIB. Mainboard versus SME sets the grids side by side.
GMP percentages on SME names run hotter because the base prices and the unofficial markets are small. A move of a few rupees is a large percentage. Hot percentages travel well in a chat. They are weak evidence of what a thin listing auction will do with real size. Treat SME GMP as a rumour about a rumour, and read GMP properly before you let it choose the issue.
Migration hopes
Some SME companies later migrate to the main board. That path can improve liquidity. It is not a plan you should underwrite at the IPO. Migration has its own conditions and its own timing, and many companies never take the step. Buy the SME listing you actually get, or do not apply. Do not apply to a future mainboard story that has not been filed.
A sober checklist
Lot size times cap, as rupees you can lose. Fresh issue versus offer for sale. The first specific risk factors, not the generic ones. Related-party note. Operating cash flow beside profit. Who is actually subscribing. Then, last, the premium, with the assumption you may not exit at it. If the cheque fails the first test, stop. The rest of the list is irrelevant to an application you cannot afford to be stuck in.
IPOWATCH keeps SME issues on their own board so this checklist has a place to start. The disclaimer is blunt about liquidity. Nothing in a high SME multiple repeals it.